Results 91 to 100 of about 263,493 (259)

Expressive Reward Synthesis with the Runtime Monitoring Language

CoRR
A key challenge in reinforcement learning (RL) is reward (mis)specification, whereby imprecisely defined reward functions can result in unintended, possibly harmful, behaviours. Indeed, reward functions in RL are typically treated as black-box mappings from state-action pairs to scalar values. While effective in many settings, this approach provides no
Daniel Donnelly, Francesco Belardinelli
openaire   +3 more sources

Deciphering Metal–Organic Framework Synthesis from Hydroxy Double Salts: In-Situ Insights via Synchrotron X‑ray Diffraction and Absorption Spectroscopy

Chem & Bio Engineering
Developing rapid room-temperature synthesis is key to sustainable manufacturing of metal–organic frameworks (MOFs). Using layered compounds such as hydroxy double salts (HDSs) as precursors significantly promotes the reaction kinetics and lowers the ...
Ming Zhang, Xinyu Luo, Yubin Hu, Yuanhao Shen, Yixin Chen, Shuchang Yuan, Hao Wang, Xueqing Xing, Junjie Zhao   +8 more
doaj   +1 more source

Eco-Friendly Silver Nanoparticles Obtained by Green Synthesis from Salvia officinalis

Sustainable Chemistry
The plant-mediated synthesis of therapeutic metal nanoparticles is an intensively exploited field in the last decade. In particular, Salvia officinalis, considered one of these plants, was used in this work to synthesize silver particles.
Anca Giorgiana Grigoras, Vasile Cristian Grigoras   +1 more
doaj   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Understanding and Tuning Fe‐Doping on Zn–Fe Layered Double Hydroxide Particle and Photocatalytic Properties

Advanced Energy & Sustainability Research
Zn‐based layered double hydroxides (LDHs) are promising photocatalytic materials, but their synthesis faces environmental and economic challenges. Oxidative ionothermal synthesis (OIS) offers a green route for zinc oxide synthesis using ionic liquids. To
Shaoqing Qu, Ruiman Ma, Igor Efimov, Eftychios Hadjittofis, Sergio Vernuccio, Kyra Sedransk Campbell   +5 more
doaj   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

In Situ Raman Spectroscopy for Early Corrosion Detection in Coated AA2024-T3

Sensors
Here we describe the synthesis and evaluation of a molecular corrosion sensor that can be applied in situ in aerospace coatings, then used to detect corrosion after the coating has been applied.
Adrienne K. Delluva, Ronald L. Cook, Matt Peppel, Sami Diaz, Rhia M. Martin, Vinh T. Nguyen, Jeannine E. Elliott, Joshua R. Biller   +7 more
doaj   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

Molecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober, Leire Moreno‐Cugnon, Laura Martínez‐Pérez, Amaia Ercilla, Amaia Zabala‐Letona, Adrián Vicente‐Barrueco, Maider Fagoaga‐Eugui, Saioa Garcia‐Longarte, Blanca Calle‐Ciborro, Encarnación Pérez‐Andrés, Onintza Carlevaris, Sara Pozo, Isabel Mendizabal, Ugo Mayor, Arkaitz Carracedo, Violaine Sée, Edurne Berra   +16 more
wiley   +1 more source